Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
No clear answers: Yes, recent actions against Chinese American scientists do pose a threat — but maybe those official concerns about espionage are valid too
7 years ago
People
In a first, HKEX receives IPO pitch from local biotech looking to make it big in crowded antibodies field
7 years ago
Financing
Elias Zerhouni: Fear of ‘targeted discrimination’ against Chinese-American scientists threatens an exodus of talent. What do you think?
7 years ago
People
Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?
7 years ago
Financing
Swiss court keeps ex-GSK scientist's brother behind bars as US pushes to extradite him on R&D theft charges
7 years ago
Incyte flips China rights of MacroGenics' PD-1 to an ambitious Zai Lab keen on leapfrogging pioneers with combos
7 years ago
Deals
Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX?
7 years ago
Financing
Genfit goes to China with a deal worth up to $228M for NASH drug
7 years ago
Deals
As Bristol-Myers/Celgene tie up loose ends, BeiGene pockets $150M from PD-1 breakup
7 years ago
Deals
Following CAR-T pioneers' footsteps, Tessa launches China JV in $120M deal
7 years ago
Financing
Cell/Gene Tx
Hansoh grabs $1B windfall in the latest China pharma IPO to hit the Hong Kong exchange
7 years ago
Financing
Foreign threats to NIH research: Senate Finance Committee digs in
7 years ago
Spreading its wings in China with global ambition, EpimAb snags $74M Series B for bispecific work
7 years ago
Financing
Fast moving Chinese regulators wave third homegrown PD-1 to market
7 years ago
Trade war, CFIUS interventions force a shift in strategy at Fosun — signaling some big potential problems for US biotechs
7 years ago
Pharma
The coming glut? Cancer cell therapy trials are booming as China rivals US on new projects
7 years ago
R&D
Ready to harvest its PD-L1, Alphamab reloads with $60M to nurture the bispecific patch
7 years ago
Financing
‘I was shocked’: Controversy brews at Emory after prominent Chinese neuroscientists are ousted over disclosure issues
7 years ago
Top 5 Chinese players: What does Everest's landmark deal with Immunomedics say about the flurry of in-licensing to China?
7 years ago
Nine listings and $3.8B later, HKEX celebrates one-year biotech anniversary with $194M CRO IPO
7 years ago
Financing
Outsourcing
MD Anderson tries to assure researchers in town hall meeting that Asian ‘ethnicity’ is not the driving force behind purge
7 years ago
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
7 years ago
Three Asian MD Anderson scientists purged in wake of NIH-directed investigations on data violations
7 years ago
Chinese pharmaceutical manufacturer in spotlight after welding accident kills 10
7 years ago
First page
Previous page
20
21
22
23
24
25
26
Next page
Last page